The present invention relates to compounds of formula I:
or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.
本发明涉及式I的化合物:或其药学上可接受的盐或混合物,其抑制
丝氨酸蛋白酶活性,特别是乙型肝炎病毒
NS3-NS4A
蛋白酶的活性。